Optimising recruitment and informed consent in randomised controlled trials: the development and implementation of the Quintet Recruitment Intervention (QRI)

被引:176
作者
Donovan, Jenny L. [1 ,2 ]
Rooshenas, Leila [1 ]
Jepson, Marcus [1 ]
Elliott, Daisy [1 ]
Wade, Julia [1 ]
Avery, Kerry [1 ]
Mills, Nicola [1 ]
Wilson, Caroline [1 ]
Paramasivan, Sangeetha [1 ]
Blazeby, Jane M. [1 ]
机构
[1] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PR, Avon, England
[2] Univ Hosp Bristol, Collaborat Leadership Appl Hlth Res & Care West, Bristol BS1 2NT, Avon, England
基金
英国医学研究理事会;
关键词
COMPLEX INTERVENTIONS; QUALITATIVE RESEARCH; RANDOM ALLOCATION; PARTICIPATION; CANCER; EQUIPOISE; ISSUES; EXPERIENCES; DESIGN; CARE;
D O I
10.1186/s13063-016-1391-4
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Pragmatic randomised controlled trials (RCTs) are considered essential to determine effective interventions for routine clinical practice, but many fail to recruit participants efficiently, and some really important RCTs are not undertaken because recruitment is thought to be too difficult. The 'QuinteT Recruitment Intervention' (QRI) aims to facilitate informed decision making by patients about RCT participation and to increase recruitment. This paper presents the development and implementation of the QRI. Methods: The QRI developed iteratively as a complex intervention. It emerged from the National Institute for Health Research (NIHR) ProtecT trial and has been developed further in 13 RCTs. The final version of the QRI uses a combination of standard and innovative qualitative research methods with some simple quantification to understand recruitment and identify sources of difficulties. Results: The QRI has two major phases: understanding recruitment as it happens and then developing a plan of action to address identified difficulties and optimise informed consent in collaboration with the RCT chief investigator (CI) and the Clinical Trials Unit (CTU). The plan of action usually includes RCT-specific, as well as generic, aspects. The QRI can be used in two ways: it can be integrated into the feasibility/pilot or main phase of an RCT to prevent difficulties developing and optimise recruitment from the start, or it can be applied to an ongoing RCT experiencing recruitment shortfalls, with a view to rapidly improving recruitment and informed consent or gathering evidence to justify RCT closure. Conclusions: The QRI provides a flexible way of understanding recruitment difficulties and producing a plan to address them while ensuring engaged and well-informed decision making by patients. It can facilitate recruitment to the most controversial and important RCTs. QRIs are likely to be of interest to the CIs and CTUs developing proposals for 'difficult' RCTs or for RCTs with lower than expected recruitment and to the funding bodies wishing to promote efficient recruitment in pragmatic RCTs.
引用
收藏
页数:11
相关论文
共 42 条
  • [1] Influence of clinical communication on patients' decision making on participation in clinical trials
    Albrecht, Terrance L.
    Eggly, Susan S.
    Gleason, Marci E. J.
    Harper, Felicity W. K.
    Foster, Tanina S.
    Peterson, Amy M.
    Orom, Heather
    Penner, Louis A.
    Ruckdeschel, John C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (16) : 2666 - 2673
  • [2] [Anonymous], 1974, Medical Experimentation: Personal Integrity and Social Policy
  • [3] The CSAW Study (Can Shoulder Arthroscopy Work?) - a placebo-controlled surgical intervention trial assessing the clinical and cost effectiveness of arthroscopic subacromial decompression for shoulder pain: study protocol for a randomised controlled trial
    Beard, David
    Rees, Jonathan
    Rombach, Ines
    Cooper, Cushla
    Cook, Jonathan
    Merritt, Naomi
    Gray, Alastair
    Gwilym, Stephen
    Judge, Andrew
    Savulescu, Julian
    Moser, Jane
    Donovan, Jenny
    Jepson, Marcus
    Wilson, Caroline
    Tracey, Irene
    Wartolowska, Karolina
    Dean, Benjamin
    Carr, Andrew
    [J]. TRIALS, 2015, 16
  • [4] What do our patients understand about their trial participation? Assessing patients' understanding of their informed consent consultation about randomised clinical trials
    Behrendt, C.
    Goelz, T.
    Roesler, C.
    Bertz, H.
    Wuensch, A.
    [J]. JOURNAL OF MEDICAL ETHICS, 2011, 37 (02) : 74 - 80
  • [5] Interventions to improve recruitment and retention in clinical trials: a survey and workshop to assess current practice and future priorities
    Bower, Peter
    Brueton, Valerie
    Gamble, Carrol
    Treweek, Shaun
    Smith, Catrin Tudur
    Young, Bridget
    Williamson, Paula
    [J]. TRIALS, 2014, 15
  • [6] Developing ethical strategies to assist oncologists in seeking informed consent to cancer clinical trials
    Brown, RF
    Butow, PN
    Butt, DG
    Moore, AR
    Tattersall, MHN
    [J]. SOCIAL SCIENCE & MEDICINE, 2004, 58 (02) : 379 - 390
  • [7] Strategies for Increasing Recruitment to Randomised Controlled Trials: Systematic Review
    Caldwell, Patrina H. Y.
    Hamilton, Sana
    Tan, Alvin
    Craig, Jonathan C.
    [J]. PLOS MEDICINE, 2010, 7 (11)
  • [8] Campbell M.K., 2007, Health Technology Assessment, V11, P1
  • [9] Developing and evaluating complex interventions: the new Medical Research Council guidance
    Craig, Peter
    Dieppe, Paul
    Macintyre, Sally
    Michie, Susan
    Nazareth, Irwin
    Petticrew, Mark
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 (7676): : 979 - 983
  • [10] Qualitative research to improve RCT recruitment: Issues arising in establishing research collaborations
    de Salis, Isabel
    Tomlin, Zelda
    Toerien, Merran
    Donovan, Jenny
    [J]. CONTEMPORARY CLINICAL TRIALS, 2008, 29 (05) : 663 - 670